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randomization were age, sex, diabetes, ischemic heart disease, blood pressure, total cholesterol, antihypertensive use, antiplatelet use, anticoagulant usage, lipid-lowering drug use, estimate of carotid luminal narrowing from duplex examination, previous ipsilateral symptoms, and previous contralateral symptoms. The risk factors recorded at follow-up were the use of the medications previously mentioned, blood pressure, and estimate of carotid luminal narrowing from repeat duplex examination.
Carotid Duplex Data
Only carotid duplex data from the randomized artery were included. The estimated degree of carotid luminal narrowing from duplex examinations was reported by investigators as a single percentage using the North American Symptomatic Carotid Endarterectomy Trial (NASCET) 18 criteria and local protocols, mostly rounded to the nearest decile. Internal carotid artery peak systolic velocity and end diastolic velocity were the most common measurements used to estimate carotid luminal narrowing. Further imaging in addition to carotid duplex was not required. The estimates were categorized according to the joint recommendations in the United Kingdom 19 and a consensus from the Society of Radiologist 20 that recommend reporting a stenosis based on these measurements in the ranges 0% to 49%, 50% to 69%, 70% to 89%, 90% to 99%, and 100%.
Changes in Carotid Luminal Narrowing
Yearly rate of change of a carotid narrowing was defined as a change in stenosis category at follow-up from the measurement 12 months previously. Yearly rate of change was given a numeric value equal to the number of categories by which the luminal narrowing had changed. Stenoses showing progression had positive rates of change, and stenoses showing regression had negative rates of change.
Data Censoring
The follow-up data were censored when the patient was lost to follow-up, had an ipsilateral neurological event, had ipsilateral surgery, had an asymptomatic ipsilateral carotid occlusion, or died. Ipsilateral events included transient ischemic attack, amaurosis fugax, stroke, and symptomatic carotid occlusion.
Statistical Analysis
Risk factor data were analyzed in Poisson regression models with ipsilateral neurological events as the outcome variable. Variables showing a significant association with ipsilateral ischemic events in a univariate model were included in a multivariate regression model. The open-source Gnumeric software was used for simple data manipulation and descriptive statistics. StatalOSE (StataCorp LP, College Station, TX) was used for complex data manipulation and regression analyses. Statistical significance was inferred at the 0.05 level.
Results
Patients and Follow-Up
The results of this analysis were derived from the data of 1469 patients at randomization and at their subsequent 6987 follow-up appointments. This equates to 7642 patient-years of follow-up. The mean length of follow-up was just >5 years. There were 5891 duplex examinations of the randomized carotid artery included in the analysis. The patients' baseline characteristics and the points at which the data were censored are shown in Table 1 . The majority of patients were male (65%). The mean age was 68 years (SD ±7.5). Two hundred forty-four patients (17%) had an ipsilateral neurological ischemic event. Of these, 134 (55%) had an ipsilateral stroke and 110 (45%) had other events attributable to the ipsilateral carotid. Twelve of the 244 patients with ipsilateral events had a symptomatic carotid occlusion; only 1 of these was a stroke.
Rate of Change of Carotid Luminal Narrowing
Carotid luminal narrowing category at randomization and last follow-up is summarized in the Figure. The majority of patients (59%) had a carotid luminal narrowing of between 70% and 90% at baseline. At the last follow-up, there was more variation within the group, but the most common (44%) luminal narrowing category remained 70% to 90%. In the first year after randomization, 89% (n=1312) had a followup carotid duplex examination. In the second year, this fell to 58% (n=845). By the fifth year, 34% (n=496) had a follow-up carotid duplex examination. The median number of carotid duplex examinations per patient was 6.4 (SE±0.33).
Yearly rate of change could be calculated for 5693 (97%) follow-ups. The majority of duplex measurements (81%) showed no change from the preceding year. In 727 (49%) patients, there were no changes in carotid luminal narrowing during their entire follow-up period. A positive yearly rate of change (progression) over 1 year was observed at 10.2% (n=582) of the follow-up duplex examinations for all patients. Progression was observed in at least 1 year of follow-up in 38.5% (n=565) of patients. For 448 patients, the greatest change in luminal narrowing over 1 year was a single 
Risk Factors for Ipsilateral Ischemic Events
Univariate regression analysis showed that 6 of the 15 potential risk factors had a statistically significant association with ipsilateral events. The results are summarized in Table 2 . All 6 were associated with increased incidence rate ratio. Ipsilateral events occurred in 58 (20.4%) of diabetic patients compared with 187 (15.8%) of nondia-betic patients. Ninetyone (21.6%) patients with previous contralateral events had an ipsilateral event compared with 154 (14.7%) patients without previous contralateral events. Although the degree of luminal narrowing itself showed a significant association with ipsilateral events, analysis of the individual categories showed that only occlusion had a significant association. The association of ipsilateral neurological events with yearly rate of change in luminal narrowing was highly statistically significant (P<0.001). Progression of carotid luminal narrowing by 1 category over 1 year was demonstrated by 512 carotid duplex examinations in 463 patients. In 29 (6.3%) patients, this was followed by an ipsilateral neurological event in the next year. Progression of 2 categories was demonstrated at 50 carotid duplex examinations in 50 patients. In 9 patients (18%), this progression was followed by an ipsilateral neurological event.
Progression of 3 categories was demonstrated at 10 carotid duplex examinations in 10 patients. In 2 patients (20%), this progression was followed by an ipsilateral event. examinations in 427 patients. In 12 patients (2.8%), reduction of carotid luminal narrowing was followed by an ipsilateral neurological event in the next year. In the remaining 36 patients who had an ipsilateral neurological event, there was no measurement of carotid luminal narrowing at the follow-up in the year before the event.
The 6 variables showing a significant association with ipsilateral events in the univariate analysis were included in a multivariate model. The result are shown in Table 3 . A significant association was maintained between ipsilateral events and both diabetes and previous contralateral symptoms. Yearly rate of change in luminal narrowing maintained a highly significant association (incidence rate ratio, 1.66; P<0.001; 95% CI, 1.27 2.16). The incidence of ipsilateral events was 4 times higher for a stenosis that had progressed by 2 categories than a stenosis that had remained unchanged and was 7 times higher for a stenosis that had progressed by 3 categories. Yearly change to 1 category higher or to any number of categories lower was not associated with an increased incidence of ipsilateral neurological events.
Discussion
All patients in this study were considered suitable for surgery but were randomly allocated to receive medical therapy alone unless symptoms developed and can therefore be considered representative of this group of patients. Approximately half of all carotid stenoses in the present study showed no change in carotid luminal narrowing during the follow-up period. When change did occur, it was as likely to be regression as progression. Approximately one third of carotid stenoses in the present study showed yearly stenosis progression at some point during follow-up, which is comparable to other studies. [15] [16] [17] [18] [19] [20] [21] The main finding of the present study is that a yearly rate of progression of 1 stenosis category was not associated with increased incidence of ipsilateral events, but higher yearly rates of progression were. The association of ipsilateral neurological events and the rate of carotid stenosis progression reported here may be underestimated. Some patients had an endarterectomy without symptoms if progression was documented. Yearly progression of a single category may lack association with an increased risk of ipsilateral events due to this underestimation, but also if the luminal narrowing regressed in subsequent years. A significant proportion of patients in the study showed progression and regression during different periods of follow-up (16%). This may represent true fluctuation in carotid luminal narrowing or, more likely, the well-recognized causes of variation in duplex measurements. 22, 23 The present study also shows that diabetes and previous contralateral symptoms were independent risk factors for neurological events ipsilateral to an asymptomatic carotid stenosis, which confirms the results of previous studies. 4, 24 Although advanced age and hypertension are well-recognized risk factors for stroke, in this study they were not independent risk factors for ischemic neurological events ipsilateral to a carotid stenosis. This lack of association has also been reported previously. 4 Unlike previous studies, the most commonly used drug classes were included in this analysis, all of which did not show an association with ipsilateral neurological events.
There are several limitations to this study. Serum creatinine levels and smoking status were not recorded in the ACST. Both are associated with an increased cardiovascular risk, 25, 26 and raised serum creatinine has been associated with an increased risk of neurological events from an asymptomatic carotid stenosis. 4 This should not affect the association observed here between the rate of stenosis progression and ipsilateral events, because there does not appear to be a strong association between stenosis progression and either serum creatinine 27 or smoking status. 28 The present analysis shows the effect of progression over relatively broad categories. These categories are appropriate because the measurements used in ACST are commonly used in clinical practice, so do not affect the applicability of the results. Future studies may be able to examine progression over narrower categories. In the ACST, there was no strict standardization of Doppler examinations between centers. Although there may be some variation in reported luminal narrowing between centers, there should be little effect on the observed rates of change. Patients attended follow-up at their local randomizing center and intrapatient variability was thus kept to a minimum. The risk of stroke from asymptomatic carotid stenoses has almost certainly fallen since the ACST data were collected 29 due to improved medical therapy. 30 Progression of carotid luminal narrowing may also have fallen in these patients due to improved medical therapy. 31 However, both of these observations are compatible with the association between ipsilateral events and fast rates of progression in carotid luminal narrowing reported here. It was not the intention of the present analysis to distinguish between stroke and transient ischemic attack. Both entities are clinical syndromes caused by the same pathological process, and the point at which a transient ischemic attack becomes a stroke is arbitrary. 32 The results presented here are generally applicable to current clinical practice and have important clinical implications when considering preventive treatments for asymptomatic carotid stenosis. In light of the current findings, duplex measurements demonstrating a slow rate of progression of an asymptomatic carotid stenosis over 1 year should not be interpreted as a sign of increased risk of future neurological events. However, faster rates of progression should be interpreted as 
